Covishield-Covaxin Mix Gives Results, Says Medical Body, Seeks More Study

The study conducted on individuals in the northern state of Uttar Pradesh in India received Covishield as the first dose followed by inadvertent administration of Covaxin as the second dose at an interval of six weeks.

The Indian Council of Medical Research (ICMR) has revealed in its study that the combination of Covaxin and Covishield vaccines, the two main vaccines of the COVID-19 vaccination programme, conducted on 18 people, has elicited better safety and immunogenicity results. The nationwide vaccination program had entered into 4th month when the event of mixed dosing raised considerable anxiety in the public domain with the potential to contributing to vaccine hesitancy. The ICMR conducted the current investigation against that backdrop. In the study, ICMR compared the safety and immunogenicity profile with those individuals who received either Covaxin or Covishield and it showed better results. The study conducted on individuals in the northern state of Uttar Pradesh in India received Covishield as the first dose followed by inadvertent administration of Covaxin as the second dose at an interval of six weeks.